https://www.pharmaceutical-technology.com/comment/maharashtras-busy-cmo-sector/ 2018-10-22T13:51:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fda-approval-dupixent-asthma/ 2018-10-22T10:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lynparza-trial-ovarian-cancer/ 2018-10-22T10:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/palbociclib-breast-cancer-trial/ 2022-07-11T08:55:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ipsen-seeks-candidates-looks-spend-e1bn-pipeline-growth/ 2018-10-19T14:28:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reimbursing-cancer-drugs-varies-europe/ 2018-10-19T11:21:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rejection-appeal-the-pfizer-australia-lipitor-case/ 2018-10-19T09:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-eisai-pharmaceutical-abbvie-otsuka/ 2018-10-19T10:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-emergent-biosolutions-pediapharm-adynxx/ 2018-10-23T11:19:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-acquires-endocyte-2-1bn/ 2018-10-19T08:54:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-gets-japanese-approval-62bn-shire-acquisition/ 2018-10-19T13:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/alzheimers-trial-2019/ 2022-07-11T08:55:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lantern-project-genzyme-perkinelmer-highlight-lysosomal-storage-disorders/ 2023-07-31T07:08:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-fine-vaccine-scandals/ 2018-10-18T10:39:52+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/sanofis-dupixent-meets-phase-iii-trial-endpoints-rhinosinusitis/ 2023-05-30T04:28:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/azs-brexit-freeze-will-short-term-uk-pharmas-future-remains-unclear/ 2018-10-17T16:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/europes-updated-guidelines-atopic-dermatitis/ 2018-10-17T10:42:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cannabis-regulations-clinical-practice/ 2023-03-15T08:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosimilar-humira-imraldi-launch-eu/ 2018-10-17T10:31:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/verge-genomics-employing-ai-to-improve-drug-discovery/ 2018-10-17T08:54:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sqz-biotech-roche-oncology-deal/ 2018-10-17T10:14:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-biologics-accounting-breach/ 2018-10-17T11:05:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-reports-sales-growth/ 2018-10-17T09:02:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/medical-supplies-to-czech-hospitals-tenders-html/ 2021-11-02T03:24:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dermiras-ad-drug/ 2023-01-10T09:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-will-continue-investment-freeze-in-uk-due-to-brexit-uncertainty/ 2018-10-16T11:37:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/56181/ 2018-10-16T09:54:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immugenyx-janssen-develop-sle-model/ 2018-10-16T11:30:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-odd-lynparza-pancreatic-cancer/ 2018-10-16T11:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allele-biotechnology-develops-sepsis-therapies/ 2018-10-16T08:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ionis-damd-drug/ 2021-12-02T12:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esmo-2018-previewing-high-impact-late-breaking-abstracts/ 2018-10-15T16:35:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brazilian-style-incentives-boost-us-biosimilar-market/ 2018-10-15T11:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pain-drug-developer-adynxx-agrees-merge-alliqua-biomedical/ 2018-10-15T12:35:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-humira-biosimilar-patent-dispute/ 2018-10-15T10:11:04+00:00 daily 2.0 https://www.pharmaceutical-technology.com/news/otsuka-proteus-expand-digital-medicines/ 2018-10-15T12:12:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/companies-create-biosimilars-for-humira/ 2018-10-15T12:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/abbvie-jjs-imbruvica-expected-post-encouraging-pfs-rates-cll/ 2018-10-12T13:41:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-celltrion-biosimilar-rituxan/ 2018-10-12T10:51:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-amicus-therapeutics-janssen-pharmaceuticals-ionis-pharmaceuticals/ 2018-10-12T09:36:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-ligand-pharmaceuticals-cvs-health-mundipharma/ 2018-10-12T11:35:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/btg-carrick-therapeutics-licensing-deal/ 2018-10-12T11:36:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-legalises-medical-cannabis/ 2018-10-12T10:37:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/allergan-us-acne/ 2022-12-07T14:03:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/abbvies-risankizumab-uptake-caveats-despite-anticipated-approvals/ 2018-10-11T10:16:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-application-esketamine-nasal-spray/ 2018-10-11T09:45:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uclh-initiates-new-trial-alzheimers-treatment-uk/ 2018-10-11T09:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-pharmaceuticals-roche-allaince/ 2018-10-11T14:40:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/breast-cancer-pipeline/ 2018-10-10T12:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/latin-america-cannabis-report-market-growth/ 2018-10-10T08:54:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-stelara-drug-unifi-trial/ 2022-07-11T08:55:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wave-life-sciences-genetic-eye-disease-therapies/ 2023-02-16T05:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amicus-penn-partner-new-gene-therapies/ 2018-10-10T11:30:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/highs-lows-hormone-replacement-therapy/ 2018-10-09T13:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-approvals-copiktras-commercial-prospects/ 2018-10-09T10:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/combo-therapies-cll/ 2018-10-09T10:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/t2d-receptor/ 2018-10-09T10:04:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-menopause-month-hrt-nonhormonal-therapies/ 2022-12-02T15:18:34+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/biogen-reports-interim-results-spinraza-nurture-study/ 2018-10-09T11:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/september-2018-top-news-stories-pharma/ 2018-10-09T14:29:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-ms-drug-siponimod/ 2018-10-09T09:26:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-bial-zebinix-data/ 2018-10-09T09:49:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cannabis-us-congress/ 2021-10-25T12:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gilead-hep-c-generercs/ 2018-10-08T13:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/idweek-2018-can-hiv-treatment-prevention-improved/ 2018-10-08T10:31:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/idweek-2018-challenges-next-steps-rsv-vaccines/ 2018-10-11T10:53:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-hemlibra-extended-fda-approval/ 2018-10-08T09:08:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-merck-hpv-vaccine-age-45/ 2018-10-08T14:27:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-england-gilead-deal-yescarta/ 2018-10-08T11:36:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/italian-pharma-tendering-set-html/ 2021-11-02T03:24:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/modest-growth-expected-asia-pacific-heart-failure-therapeutics-market/ 2018-11-26T10:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ketamine-based-drugs-horizon-trd/ 2018-10-05T10:08:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/antimicrobial-stewarship/ 2018-10-05T10:07:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/easd-2018-jardiance-future-t1d-space/ 2022-03-15T07:01:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/healthcare-access-challenge-sandoz/ 2022-07-18T10:15:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-advent-international-roche-clinigen-group/ 2021-11-22T07:10:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-type-2-diabetes-trial/ 2022-07-11T08:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-janssen-pharmaceutical-novartis-novo-nordisk/ 2018-10-05T09:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-arrowhead-licence-agreements/ 2021-12-01T10:25:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/norwegian-pharma-industry-calls-for-tendering-and-irp-reforms-html/ 2021-11-02T03:24:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertexs-cf-drugs-denmark-amgros/ 2018-10-04T14:43:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/insulin-sglt-inhibitors-dominate-late-stage-type-1-diabetes-pipeline/ 2018-10-04T13:03:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/nhs-genomic-medicine-service-uk/ 2019-12-23T10:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/t2d-pioneer-trial/ 2022-07-11T08:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/55243/ 2018-10-04T10:27:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/concerns-over-brexit-stop-trials-uk/ 2022-07-11T08:55:41+00:00 daily 3.0 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-b-cell-lymphoma-therapy-japan/ 2018-10-04T14:34:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-hifibio-therapeutics-alliance/ 2018-10-04T11:33:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-boston-pharmaceuticals-licensing/ 2018-10-04T13:28:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gene-cell-therapies-making-manufacturing-work/ 2018-10-03T16:15:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/easd-2018-struggles-gsks-glp-1-receptor-agonist/ 2018-10-03T13:54:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/masters-speciality-pharma-emerging-markets/ 2018-10-04T09:30:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/therapy-trials-oncology/ 2018-10-03T13:15:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/clinical-development-biologics/ 2018-10-05T16:26:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/patient-death-following-car-t-therapy-manufacturing/ 2022-03-24T10:47:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-dragonfly-therapeutics-cancer-drugs/ 2018-10-03T10:30:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recipharm-buys-sanofi-inhalation-business/ 2018-10-03T10:27:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alliance-pharma-xonvea-launch/ 2018-10-03T10:13:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/reduce-cross-contamination-risk-single-use-isolator-technology/ 2020-01-16T10:14:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-aldeyras-reproxalap-beat-blockbusters-dry-eye-market/ 2023-03-03T11:22:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/big-pharma-hepatocellular-carcinoma/ 2018-10-02T10:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/enthusiasm-checkpoint-inhibitor-combination/ 2018-10-02T10:10:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-and-the-environment-pollution-trend/ 2024-08-16T03:39:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enesi-pharma-phe-vaccine-deal/ 2018-10-02T11:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-sells-zentiva/ 2018-10-02T12:00:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/prescriber-preferences-blocking-biosimilar-uptake-ra/ 2022-03-28T07:14:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/live-biotherapeutic-products/ 2018-10-01T12:37:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/parkinsons-microbiome-based-therapeutics/ 2018-10-01T12:25:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-symtuza/ 2018-10-01T11:38:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-acquires-tusk-therapeutics/ 2018-10-01T10:14:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-cellular-kymriah-in-china/ 2018-09-28T14:18:35+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/neuro-immunology-evolving-field-strong-pipeline/ 2022-08-18T10:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/issue-reproducibility-science/ 2018-09-28T13:58:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/skin-grafts-gene-editing/ 2023-01-04T11:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-special-issue/ 2019-12-23T10:54:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-mylan-daiichi-sankyo-takeda/ 2018-09-28T09:52:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-cuba-innovative-immunotherapy-alliance-cancer/ 2018-09-28T10:33:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-alzheimers-market-offers-scope-disease-modifying-drugs/ 2018-09-28T10:03:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/soft-robot-to-be-used-for-drug-delivery/ 2018-09-28T10:26:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/uk-postbrexit-participation-in-unified-patent-court-html/ 2021-11-02T03:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brazil-gilead-patent-hepatitis-c-sovaldi/ 2018-09-27T15:44:23+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/chmp-orphan-drugs-ec-approval/ 2018-09-27T15:24:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/amazon-pillpack-unstoppable-pharmacy-force/ 2018-09-27T14:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/moderna-therapeutics-ipo-mrna/ 2018-09-27T10:31:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ema-biosimilar-use/ 2018-09-27T10:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-imfinzi-improves-overall-survival/ 2018-09-27T10:50:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tris-pharma-buys-pfizers-nextwave/ 2018-09-27T10:36:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-buys-syntimmune/ 2023-05-30T03:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/hta-adoption-in-asian-emerging-pharma-markets-html/ 2021-11-02T03:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/usb-port-human-genome/ 2018-09-26T10:36:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/anticoagulants-cancer-patient/ 2018-09-26T10:08:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/top-ten-clinical-research-organisations/ 2024-06-18T10:02:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-hcv-generic-drugs-cheaper/ 2018-09-26T11:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-alzheimers-therapy-approach/ 2018-09-26T11:11:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-job-cut-switzerland-uk/ 2018-09-26T11:07:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/wipo-ifpma-pharma-database-patinformed/ 2018-09-25T15:14:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brexit-eu-uk-mhra/ 2018-09-25T13:45:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immutep-partners-merck-pfizer-cancer-drug-trial/ 2022-07-11T08:55:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enesi-pharma-wrair-partner-develop-vaccine-shigella-infection/ 2018-09-25T09:46:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-compound-chronic-inflammation/ 2022-12-28T09:42:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/hereditary-alzheimers-cure/ 2018-09-25T09:11:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cmos-can-benefit-single-use-solutions/ 2020-01-16T10:14:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-fujifilm-europe-humira-biosimilar/ 2018-09-24T10:51:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amicus-therapeutics-buys-celenex/ 2023-03-23T11:08:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abpi-signs-five-year-agreement-ahsn/ 2018-09-24T11:20:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/world-alzheimers-day-treatments/ 2018-09-21T15:49:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nhs-landmark-ruling-against-companies-amd/ 2022-12-26T12:16:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-molecular-templates-alliance/ 2018-09-21T11:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-leo-pharma-valeo-pharma-allergan/ 2018-09-21T09:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovate-uk-ai-drug-discovery/ 2019-12-23T10:54:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/linearx-takis-alliance/ 2018-09-21T10:51:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/chinese-pharma-manufacturing/ 2021-12-02T06:30:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-75/ 2023-04-12T06:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/stroke-increases-risk-dementia/ 2021-12-03T10:05:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/measles-cases-hit-record-high-europe/ 2018-09-21T08:15:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-lay-off/ 2018-09-20T10:47:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/malaria-infection/ 2023-05-31T04:55:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zika-vaccine-brain-cancer/ 2018-09-20T10:40:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/regulatory-convergence-or-divergence-for-asian-pharma-html/ 2021-11-02T03:24:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/diamond-thermo-fisher-ebic-em-pharma/ 2019-12-23T10:52:59+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/abbvie-humira-kickbacks/ 2018-09-19T11:15:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-research-hub/ 2018-09-19T11:12:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/paediatric-clinical-research/ 2018-09-19T11:07:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-to-fight-drug-addiction-prescription/ 2023-01-23T13:32:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dupilumab-atopic-dermatitis/ 2018-09-18T11:08:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/strong-growth-expected-orphan-rare-dermatology-premium-products-market/ 2022-12-07T14:08:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/adaptvac-emergence-virus-like-particle-vaccines-breast-cancer/ 2018-09-18T09:36:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/patients-recruited-blood-cancer-trial-backed-leukemia-lymphoma-society/ 2021-10-27T12:26:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-migraine-drug-ajovy/ 2018-09-18T10:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stem-cell-therapies-diabetes/ 2018-09-18T11:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daily-aspirin-healthy-adults/ 2021-10-29T05:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lumoxiti-hairy-cell-leukaemia/ 2018-09-17T10:41:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-buys-bonti/ 2018-09-17T11:28:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/impurity-in-valsartan-products/ 2018-09-17T10:51:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/bristol-myers-squibb-change-psoriasis-market/ 2018-09-14T15:46:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brexit-and-the-pharmaceutical-industry-no-deal-drug-precursors/ 2018-09-14T14:49:46+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/crisaborole-atopic-dermatitis/ 2018-09-18T10:32:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-cambrex-corporation-boehringer-ingelheim-supernus-pharmaceuticals/ 2018-09-17T09:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-walgreens-novartis-active-biotech/ 2018-09-17T09:05:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clearance-veyvondi-europe/ 2018-09-14T11:01:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-sickle-cell-disease-initiative/ 2022-12-09T12:29:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-buys-viratherapeutics/ 2018-09-14T11:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/court-upholds-crispr-patents-ruling/ 2019-12-23T10:52:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eadv-2018-first-real-life-data-studies-atopic-dermatitis-patients-dupilumab/ 2023-06-26T05:47:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/non-antibiotic-drug-tuberculosis/ 2018-09-13T11:13:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-merck-rcc-cancer-therapy/ 2022-11-25T16:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/oncology-biosimilars-7-major-markets/ 2018-09-12T15:32:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/high-cost-contamination-drugs-manufucaturing/ 2020-01-16T10:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-links-common-arthritis-drug-azathioprine-skin-cancer/ 2018-09-12T11:10:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/court-invalidates-ampyra-patents/ 2018-09-12T11:12:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/consort-delivery-device-opioid-overdose-drug/ 2018-09-12T11:14:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/syphilis-will-remain-global-burden-next-decade/ 2018-09-11T11:19:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/concert-pharmas-phase-iia-alopecia-areata-study-may-lack-cosmetic-relevance/ 2018-09-11T11:13:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/return-blockbusters-immuno-oncology/ 2023-02-28T04:53:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-mepolizumab-copd/ 2018-09-11T11:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/invokana-and-vokanamet-europe/ 2018-09-11T11:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/xencors-lupus-drug-evokes-tepid-expert-response-phase-ii-study/ 2018-09-10T16:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-nhs-use-roches-ocrevus-ppms/ 2018-09-18T09:51:41+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/blood-cancer-awareness-month/ 2022-07-21T11:32:18+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/medopad-acquires-sherbit/ 2018-09-10T10:46:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-amgen-tezepelumab/ 2018-09-10T11:36:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/walgreens-auvi-q-epipen-shortage/ 2018-09-10T15:38:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/car-t-europe-nice-verdict/ 2018-09-07T12:31:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/contrafects-staph-infection-drug-may-succeed-trial-caveats-remain/ 2022-07-11T08:55:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-olon-spa-mannkind-shire/ 2018-09-07T09:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chi-meds-fruquintinib/ 2023-02-28T05:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-laquinimod-active-biotech/ 2018-09-07T11:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-sotio-united-therapeutics-pediapharm/ 2018-09-07T09:23:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-buys-sanaplasma/ 2018-09-07T10:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sdoh-drug-compliance/ 2018-09-06T16:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/azs-imfinzi-combo-will-struggle-dislodge-first-line-nsclc-competitors/ 2018-09-06T10:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/car-t-strive-01-study-points-novel-approach-solid-tumours/ 2018-09-06T10:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/novartiss-pi3k-inhibitor-beats-roche-hr-her2-breast-cancer/ 2018-09-06T09:51:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/childhood-cancer-treatment-nhs-fund-car-t/ 2019-12-23T10:52:59+00:00 daily 4.0 https://www.pharmaceutical-technology.com/news/immunotherapy-prostate-cancer/ 2018-09-06T11:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-divest-sandoz-us-portfolio/ 2018-09-06T10:54:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayers-prescription-dermatology/ 2022-11-29T15:41:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/humira-abbvie-drug/ 2024-06-18T10:04:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/immuno-oncology-blockbuster-drugs/ 2023-02-28T04:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/act-resistance-malaria/ 2018-09-05T10:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/venclexta-set-challenge-imbruvicas-dominance-cll-market/ 2018-09-05T10:04:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/genentech-partnership-sends-affimeds-shares-soaring/ 2018-09-05T09:53:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/migraine-awareness-week-repurposing-drugs/ 2018-09-05T09:28:31+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/evox-therapeutics-raises-new-funds/ 2018-09-05T11:02:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-bribery-charges/ 2018-09-05T10:56:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mannkind-agreement-united-treprostinil/ 2018-09-05T11:24:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/promising-dmt-candidatelzheimers-disease-could-reach-trials-in-2019/ 2022-07-11T08:55:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/expanding-generics-biosimilars-in-india/ 2022-02-11T04:51:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aimmune-fda-peanut-allergy/ 2018-09-04T10:16:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/redhill-transform-treatment-gi-diseases/ 2023-04-04T08:58:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucla-more-antibiotic-combinations-effective/ 2018-09-04T11:41:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-links-stroke-dementia-risk/ 2018-09-04T11:01:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofis-cablivi-ec-approval/ 2018-09-04T10:45:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/parp-inhibitors-china/ 2021-10-27T12:54:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amgens-blincyto-approval/ 2018-09-03T10:58:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cannabinoids-breakthrough-signals-hope-epilepsy-treatment/ 2021-11-22T07:37:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-researcher-steal-trade-secrets/ 2018-09-03T10:59:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-oncology-servier-2-4bn/ 2018-09-03T10:51:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regenxbio-rgx181-drug-cln2/ 2023-03-23T11:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esc-congress-2018-cancer-patients-af-take-doacs-instead-warfarin/ 2022-07-11T08:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jama-study-fda/ 2018-08-31T14:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/plaque-psoriasis-strong-phase-iii-results-expected-ucbs-bimekizumab/ 2022-07-20T04:14:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/drug-supply-post-brexit-may-occur-expense-pharma-rd/ 2018-08-31T11:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/novo-nordisk-invests-glucose-binding-tech-stay-ahead-diabetes-market/ 2018-08-31T10:56:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ibudilast-slows-brain-shrinkage-nih/ 2018-08-31T11:07:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-bluebird-bio-tjoapack-emergent-biosolutions/ 2018-08-31T11:02:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-genomics-partner-genetics/ 2018-08-31T11:01:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/haemophilia-a-drug-fda-approval/ 2018-08-31T11:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hcc-bayer-lenvima/ 2018-08-30T12:39:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/renaissance-psilocybin-viable-treatment-option/ 2018-08-30T13:13:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/trump-building-wall-opioid-addiction-cmos/ 2018-08-30T11:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-acquires-adapt-pharma/ 2018-08-30T11:45:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/british-columbia-files-lawsuit-players-opioid-industry/ 2018-08-30T11:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-nice-rejects-use-gileads-yescarta-nhs-cost-concerns/ 2018-08-30T11:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/campaign-stockpiling-medicines-for-a-no-deal-brexit-2bn/ 2018-08-29T14:54:02+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/drones-to-transport-medical-supplies-att-softbox/ 2019-12-23T10:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/not-used-businesses-wire-ceo-whatsapp-update/ 2019-12-23T10:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/antivirals-ebola-congo/ 2018-08-29T12:47:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esc-congress-2018-debating-role-cholesterol-busting-drugs/ 2018-08-29T12:45:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ezh2-drug-cancer/ 2021-11-25T11:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/philanthropy-ispe-foundation/ 2018-08-20T09:54:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/studies-constant-risk-cv-events/ 2018-08-29T15:08:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tjoapack-veratrak-blockchain-tool-pharma/ 2018-08-29T10:48:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/affimed-cancer-therapeutics-genentech/ 2018-08-29T10:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/esc-congress-2018-future-pcsk9-inhibitors/ 2018-08-28T15:49:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/abortion-in-england-home-use-pills/ 2018-08-28T15:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-rtor-programme/ 2018-08-28T13:47:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-coheruss-biosimilars/ 2021-11-22T07:12:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/half-century-innovation-tells-us-tech-industry/ 2019-12-23T10:53:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/move-gdpr-new-eprivacy-regulation-affect-businesses/ 2019-12-23T10:57:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/brexit-and-the-pharmaceutical-industry-no-deal/ 2018-08-28T08:25:42+00:00 daily 4.0 https://www.pharmaceutical-technology.com/news/leo-pharma-jw-pharmaceuticals-jw1601/ 2018-08-28T11:39:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-european-commissions-approval-kymriah/ 2018-08-28T07:40:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-tafamidis-heart-disease/ 2018-11-26T10:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/research-chronic-migraine/ 2022-02-15T07:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/august-2018-top-news-stories-pharma/ 2018-09-24T12:13:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roches-rituxan-biosimilar-woes-just-beginning/ 2018-08-24T09:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/competition-heats-oral-antidiabetic-drugs-t1d/ 2018-08-24T09:34:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/potential-universal-flu-vaccine/ 2018-08-24T11:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxervate-approval-neurotrophic-keratitis/ 2018-08-24T11:09:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-tolero-pharmaceuticals-biontech-novo-nordisk/ 2018-08-24T09:11:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bio-gritstone-cancer-therapies/ 2018-08-24T10:59:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/blockbuster-asthma-drug-xolair-gains-breakthrough-status-food-allergies/ 2018-08-23T15:49:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/will-part-b-step-edits-impact-us-biosimilar-uptake/ 2018-08-23T15:28:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-74/ 2023-04-21T09:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/globaldatas-top-20-financial-advisery-firms/ 2020-10-28T05:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/globaldatas-top-20-legal-advisery-firms/ 2020-10-28T05:23:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hemlibra-hemophilia-a/ 2018-08-23T11:01:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vistusertib-and-paclitaxel-shrinks-tumours/ 2018-08-23T11:08:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tracelink-funding-digitalise-supply-chain/ 2018-08-23T11:04:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sierra-acquires-gilead-momelotinib/ 2018-08-23T10:57:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/statutory-pricing-proposal-barrier-biosimilars-uk/ 2018-08-22T15:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/us-most-expensive-drugs-uk-prices/ 2024-09-17T10:18:51+00:00 daily 2.0 https://www.pharmaceutical-technology.com/news/astrazenecas-tagrisso-japan-nsclc/ 2018-08-22T15:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gene-therapy-technology-with-bluebird-bio/ 2021-11-23T05:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-uptake-infliximab/ 2018-08-22T12:39:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ebola-experimental-vacc/ 2018-08-22T12:19:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/mymedsme-drug-safety-monitoring-data-technology/ 2019-12-23T10:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hiv-viral-suppression-rates-nearly-triples-art/ 2018-08-22T10:58:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinese-regulatory-authority-approves-roches-alecensa/ 2018-08-22T10:33:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tumour-dna-scale-personalised-medicine/ 2018-08-22T10:46:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/alzheimers-data-biogen/ 2018-08-21T14:50:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/viiv-secures-key-phase-iii-win-monthly-injectable-hiv-regimen/ 2018-08-21T10:38:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harbour-350m-anti-pd-l1-kelun-biotech/ 2018-08-21T11:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tolero-abbvie-aml-therapy/ 2018-08-21T11:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/australia-opioid-induced-deaths/ 2023-05-31T06:22:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/people-vs-big-pharma-tackling-industrys-trust-issues/ 2024-10-07T08:58:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-pertuzumab-her2-positive-breast-cancer/ 2018-08-20T12:26:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/allergan-abicipar-amd/ 2018-08-20T13:12:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-profectus-cepi-lassa-virus-vaccine/ 2018-08-20T10:30:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opdivo-small-cell-lung-cancer/ 2023-01-04T11:07:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-acquires-ziylo-800m/ 2018-08-20T10:21:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/causes-of-pharmaceutical-contamination/ 2019-11-21T10:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/ilc-dover-flexible-isolators/ 2019-11-21T10:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-generic-mylan-epipen/ 2018-08-17T13:25:06+00:00 daily 2.0 https://www.pharmaceutical-technology.com/comment/want-break-chinese-vaccine-market/ 2018-08-17T10:56:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/zavante-deal-nabriva-poised-launch-two-first-class-antibiotics/ 2018-08-17T10:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/revlimid-demonstrates-positive-phase-iii-results-indolent-nhl/ 2018-08-17T10:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-aralez-pharmaceuticals-perrigo-takeda/ 2018-08-17T09:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nui-galway-ire1-stress-response-tnbc/ 2018-08-17T10:56:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fasinumab-osteoarthritis-trial-success/ 2022-07-11T08:55:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-425m-flu-vaccine-pfizer/ 2023-04-20T02:20:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ema-gives-prime-status-promising-huntingtons-treatment/ 2023-05-09T06:25:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-seeks-harmony-eu-ctr-nhs-pharma-stockpile-drugs/ 2018-08-16T14:56:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/realm-therapeutics-failure-pr022-eczema/ 2018-08-16T14:20:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-viiv-results-two-drug-hiv-1/ 2018-08-16T11:49:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/hackers-can-fool-doctors-fake-vital-signs-rich-powerful-need-worry/ 2019-12-23T10:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rxi-karolinska-institutet-solid-tumour-therapy/ 2018-08-16T11:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-nda-motif-bios-iclaprim/ 2018-08-20T13:30:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-study-reverses-congenital-blindness/ 2018-08-16T11:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/is-healthcare-reform-in-the-cards-81618-html/ 2021-11-02T03:24:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nusinersen-nice-not-recommend-sma/ 2018-08-15T13:52:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/remifentanil-pain-relif-standard-care/ 2018-08-15T13:42:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/big-soil-genentech-lodo-launch-1bn-project-develop-new-drugs-earth/ 2018-08-10T13:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gene-therapy-bubble-boy-disease/ 2018-08-15T09:41:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-nda-japan-intuniv-adhd/ 2018-08-15T09:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/phrma-survey-research-development/ 2018-08-14T15:15:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-first-contraceptive-app-natural-cycles/ 2018-08-15T08:45:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/stages-of-clinical-trials-drugs/ 2022-08-08T11:09:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-lillys-phase-iii-trial-tanezumab-osteoarthritis-still-draws-caution/ 2022-07-11T08:55:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/survey-shows-pharmas-doubts-brexit-outcome/ 2018-08-14T10:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/human-level-intelligent-machines-will-arrive-decade-technology-industry-veteran/ 2019-12-23T10:54:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ai-design-personalised-combination-therapy/ 2018-08-14T15:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-acquires-quethera-108-5m/ 2018-08-14T15:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylam-fda-approval-onpattro/ 2018-08-14T11:27:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/achillions-c3g-trial-earmarked-success-despite-slow-recruitment/ 2018-08-13T16:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cutting-mediators-let-cancer-research-off-leash/ 2018-08-13T16:06:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-drug-stockpiling-begins-cmos-complain-brexit-uncertainty/ 2018-08-13T15:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-pathogenic-mechanism-ipf/ 2021-12-03T10:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-suspends-vertexs-symkevi-cf/ 2018-08-13T11:57:11+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/aralez-divests-core-businesses-250m/ 2018-08-13T14:39:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/perrigo-separate-rx-business/ 2018-08-20T11:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-acquire-paxvax-270m/ 2023-01-06T13:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-investigation-changsheng-rabies-vaccine/ 2018-08-10T14:06:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-first-generic-cgt-designation/ 2018-08-10T11:35:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-cells-release-pdl1-fight-immune-system-research/ 2018-08-10T11:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-pharmaxis-almirall-cipla-quality-chemical-industries/ 2018-08-10T09:46:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ambys-medicines-takeda-therapies-liver-diseases/ 2018-08-10T14:49:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-poteligeo-two-lymphoma/ 2018-08-10T14:58:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/top-companies-ibd-space/ 2018-08-09T15:47:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/akceas-cardiovascular-drug-meet-phase-iii-benchmarks-cvot/ 2018-08-09T15:36:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/spark-therapeutics-q2-financial-results-income-growth-luxturna/ 2018-08-09T14:31:33+00:00 daily 1.0 https://www.pharmaceutical-technology.com/sponsored/powder-containment-experts-interview-ilc-dover-chief-executive-fran-dinuzzo/ 2020-01-16T10:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/powder-containment-vital-pharmaceutical-industry/ 2019-10-15T04:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/safe-powder-containment-ez-biopac-ilc-dover-reducing-risk/ 2019-10-15T04:40:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/continuous-liner-systems-ensure-safe-transfer-pharmaceutical-ingredients/ 2019-10-15T04:40:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-q2-financial-results-revenue-decline-sales-north-america/ 2018-08-09T12:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-air-freight/ 2018-08-02T15:13:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/amyotrophic-lateral-sclerosis-market/ 2018-08-09T07:50:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-vertexs-cf-orkambi-children/ 2018-08-09T11:25:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/array-biopharma-mcrc-therapy-breakthrough/ 2018-08-09T11:00:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seattle-childrens-car-t-cell/ 2018-08-09T10:51:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gossamer-decide-lead-autoimmune-candidate-strategy-end-2018/ 2021-11-23T08:20:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pioneering-stem-cell-trial-parkinsons-disease-begins-japan/ 2018-08-08T15:58:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-genetics-crispr-engineered-mammalian-cell-lines/ 2018-08-08T14:17:49+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/methylphenidate-effective-adhd-drug/ 2018-08-08T14:01:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amazons-future-us-healthcare/ 2018-08-08T13:42:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jp-morgan-tops-globaldata-financial-healthcare-mergers/ 2018-08-08T12:54:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/acute-ischemic-stroke-market-growth/ 2018-08-08T08:53:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-post-brexit-clinical-trials-regulation/ 2022-07-11T08:55:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alzheon-3spa-inhibits-alzheimers/ 2018-08-08T11:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-regeneron-collaborate-cancer-cell-therapies/ 2018-08-08T10:53:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-innovation-mat-opioid-addiction/ 2018-08-08T10:17:17+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/italy-ends-obligation-to-vaccinate-children/ 2018-08-07T11:41:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/antimalarials-treatment-malaria/ 2023-05-31T04:55:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-harbour-biomed-oncology-candidate-china/ 2018-08-07T11:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-nicotine-replacement-therapies/ 2018-08-07T11:11:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alliance-gene-therapy-for-cystic-fibrosis/ 2018-08-08T10:42:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharmaceutical-manufacturing-companies-in-india/ 2024-05-10T07:12:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-claim-uncover-thalidomide-defects/ 2018-08-06T13:30:21+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/mmv-steps-elimination-malaria/ 2023-05-31T04:56:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-divests-dermatology-medicines-almirall-550m/ 2023-01-19T07:42:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-merck-ema-orphan-status-selumetinib/ 2018-08-06T10:50:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shorter-tuberculosis-therapy-effective/ 2018-08-06T10:57:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/alzheimers-disease-still-hope-amyloid-hypothesis/ 2018-08-03T13:36:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/un-eca-develop-african-pharma/ 2018-08-03T11:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-attempts-plug-stem-skills-shortage-science-visa-scheme/ 2019-12-23T10:53:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/brazil-trial-enrolment-rate-dips-site-numbers-soar/ 2018-08-03T10:15:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-xeljanz-marketing-authorisation-europe/ 2018-08-03T10:37:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-daiichi-sankyo-mannkind-dova-pharmaceuticals/ 2018-08-03T09:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/walter-eliza-hall-institute-cancer-cells-sleep/ 2018-08-03T14:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/july-2018-top-news-stories-pharma/ 2018-08-06T13:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ptc-therapeutics-commercialise-akcea-rare-drugs/ 2021-11-25T10:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-grifols-shared-services-north-america-takeda/ 2021-11-22T14:31:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-shinogi-mulpleta-cld-thrombocytopenia/ 2023-03-23T10:30:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-first-oncology-biosimilar-europe/ 2018-08-02T15:16:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/51-businesses-couldnt-cope-data-breach/ 2019-12-23T10:57:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roches-modul-crc-results-inbound-january-2019/ 2018-08-02T14:27:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/abbvie-poised-overtake-gilead-hepatitis-c-leader/ 2018-08-02T14:23:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/antibiotics-crohns-disease/ 2018-08-02T13:52:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/nabriva-therapeutic-antibiotics/ 2018-08-02T13:26:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/paying-bill-innovative-gene-cell-therapies/ 2018-08-01T14:11:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/alzheimers-disease-pipeline/ 2018-08-02T10:18:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-tigenix-acquisition-608m/ 2018-08-02T14:11:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leo-pharma-bayer-prescription/ 2018-08-02T11:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unc-ai-drug-development/ 2018-08-02T11:37:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-q1-2018-financial-results-growth-confidence-full-year/ 2018-08-01T14:43:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-q2-financial-results-emerging-markets/ 2018-08-01T14:44:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fdas-approach-tackling-injectable-drug-shortages/ 2018-08-01T13:26:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/serialisation-needed-drive-pharma-industry-blockchain-adoption/ 2022-02-22T04:57:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/robust-revenue-growth-agios-contingent-label-expansion/ 2018-08-01T13:34:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trinetx-using-real-world-data-improve-clinical-research/ 2019-12-23T10:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/novartis-entresto-cost/ 2018-08-01T12:44:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/viiv-hiv-treatment/ 2018-08-01T12:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/time-talk-breast-cancer-chemoprevention/ 2018-08-01T10:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-transfer-41-products-alfresa/ 2018-08-01T11:52:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-migraine-aimovig-ec-approval/ 2022-11-08T14:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-doj-probe-allege-terrorists/ 2018-08-01T13:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/immunising-opioids-vaccine/ 2018-07-31T15:12:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-ocrevus-blockbuster-status/ 2018-07-31T14:41:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-reject-insys-opioid-buvaya/ 2018-07-31T13:59:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/future-hold-us-biosimilars/ 2018-07-31T13:19:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/influence-coagulation-cascade-targets-cvd/ 2018-07-31T12:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-bioethics-panel-finds-human-genome-editing-ethically-acceptable/ 2018-08-06T09:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mannkind-distribution-deal-tanner-diabetes/ 2018-07-31T11:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indivior-fda-perseris-schizophrenia/ 2018-07-31T11:08:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-cancer-research-dana-farber/ 2018-11-15T13:43:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cstone-mek-inhibitor-cs3006-trial-china/ 2022-12-20T09:22:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/world-hepatitis-day-2018-89-percent-unaware/ 2018-07-30T14:56:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tafenoquine-set-rapid-uptake-p-vivax-malaria/ 2018-07-30T14:27:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/luspatercept-acceleron-celgene/ 2018-07-30T13:20:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/outcome-based-contracts-kymriah/ 2023-01-17T10:16:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/big-pharma-shies-away-investment-acute-coronary-syndrome/ 2018-07-30T11:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-chinese-approval-keytruda/ 2018-07-30T15:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-legalise-cannabis-derived-medicinal-products/ 2018-07-30T11:43:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pierre-fabre-chmp-positive-opinion-melanoma/ 2018-07-30T11:42:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-q2-results-sales-upgrade-fy/ 2021-11-02T06:39:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ema-brexit-alarm-bells-healthcare-industry/ 2022-07-19T11:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-q2-financial-results-products-growth/ 2018-07-27T14:29:44+00:00 daily 2.0 https://www.pharmaceutical-technology.com/comment/schizophrenia-symptoms/ 2023-01-09T11:14:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/trumps-hard-stance-pharma-criticised-insiders-supported-many/ 2018-07-27T11:16:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/stem-cell-therapies-cvmd/ 2022-11-17T14:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chugai-expand-singaporean-research/ 2021-10-31T14:59:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-ptc-therapeutics-cambrex/ 2018-07-27T09:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-prepares-stockpile-supplies-nodeal-brexit/ 2018-07-27T10:44:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alector-133m-alzheimers-drugs/ 2021-11-22T10:27:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-astrazeneca-biogen-midatech-pharma/ 2018-07-27T09:23:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-adjusts-fy-guidance-q2/ 2018-07-26T15:53:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-h1-new-drugs-emerging-markets-growth/ 2018-07-26T15:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tnbc/ 2018-08-07T15:57:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-therapies-cvmd/ 2023-03-01T08:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-atacands-european-rights/ 2018-07-27T03:29:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-tsinghua-university-research-collaboration/ 2018-07-26T11:00:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-300m-23andme-drug-development/ 2018-07-26T10:55:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-abbvies-endometriosis/ 2022-11-29T14:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/britain-needs-improve-data-skills-survive-post-brexit/ 2019-12-23T10:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/intelligent-automation-boost-global-financial-revenue-500bn-2020/ 2019-12-23T10:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/two-companies-using-ai-treat-orphan-diseases/ 2019-12-23T10:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-will-force-millions-switch-careers-next-two-decades-pwc/ 2019-12-23T10:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/smishing-guide-latest-cyber-threat/ 2019-12-23T10:57:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cryptocurrency-regulation-uk-enough/ 2019-12-23T10:56:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/great-firewall-china-digital-economy-thrives-despite-robust-internet-regulations/ 2019-12-23T10:57:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ai-space-augmentation-future-according-serial-tech-investor/ 2019-12-23T10:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dutch-viagra-trial-pregant-babies-die/ 2018-07-25T14:52:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/osteoporosis-patient-compliance/ 2023-01-04T11:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/47408/ 2021-12-02T09:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/end-struggle-pathways-heal-opioid-crisis/ 2021-12-02T06:53:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-1bn-alliance-anima-biotech/ 2018-07-26T10:18:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gossamer-bio-230m-growth-expansion/ 2021-11-23T08:21:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-build-465m-facility-us/ 2018-07-25T11:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/curing-hepatitis-c-fraction-cost/ 2018-07-24T15:43:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-probe-changsheng-rabies-vaccine/ 2018-07-24T15:35:59+00:00 daily 2.0 https://www.pharmaceutical-technology.com/news/uk-health-secretary-hancock-priorities-nhs/ 2018-07-24T14:55:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/artificial-intelligence-oncology/ 2018-07-24T12:47:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/long-term-adherence-biological-dmard-therapy-adherence-persistence-first-year-key-success/ 2018-07-24T12:34:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agios-tibsovo-fda-approval-aml-treatment/ 2018-07-24T11:24:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-puretech-antisense-oligonucleotide/ 2021-11-22T10:49:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cambrex-buy-halo-425m/ 2018-07-26T13:03:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofi-regenerons-cemiplimab-will-sixth-marketed-pd-1-pd-l1-inhibitor/ 2022-03-24T10:16:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinese-ping-an-trade-license/ 2018-07-23T15:34:29+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/15-drug-compounding-facilities-violated-fda-regulations/ 2018-07-23T14:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazenecas-lynparza-maintains-lead-parp-inhibitor-race/ 2018-07-23T12:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-astrazenecas-asthma/ 2018-07-23T11:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kite-partners-gadeta-develop-new-cancer-therapies/ 2018-07-26T13:02:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-deal-morphosys-galapagos/ 2018-07-26T13:01:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-priority-review-krintafel-prevent-malaria-relapse/ 2018-07-23T10:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-phase-3-gene-therapy-haemophilia/ 2018-07-20T14:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unc-lineberger-new-target-kidney-cancer/ 2018-07-20T14:15:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/illegal-online-pharmacies-endemic/ 2018-07-23T09:19:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-merck-apotex-dare-bioscience/ 2018-07-20T08:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eusa-pharma-acquire-janssen-sylvant/ 2018-07-26T12:58:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-indication-novartis-kisqali/ 2018-07-20T11:35:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/report-more-women-pl-pharma/ 2018-07-20T11:33:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-73/ 2023-04-12T06:12:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-stockpile-no-deal-brexit/ 2018-07-19T15:21:35+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/novartis-postpones-drug-price-hike/ 2018-07-19T13:53:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-fda-breakthrough-tecentriq-combination/ 2018-07-19T10:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roivant-startup-sinovant-china/ 2018-07-19T11:38:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-revolution-medicines-cancer/ 2018-07-19T11:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-orphan-drug-designation-asceneurons-asn120290/ 2018-07-18T15:18:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/population-boom-will-boost-acute-stroke-market-particularly-china/ 2018-07-18T14:45:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/epilepsy-pharmas-epidiolex/ 2021-11-30T12:10:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-government-loses-ema-amendment-brexit-bill/ 2018-07-18T11:37:00+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/crispr-cas9-gene-editing-greater-dna-damage/ 2018-07-18T11:22:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-janssens-symtuza-hiv1/ 2018-07-18T10:49:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-patent-deal-mylan-humira-biosimilar/ 2018-07-18T11:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/psoriasis-drug/ 2022-12-20T10:20:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-akcea-ionis-inotersen-marketing/ 2018-07-17T14:58:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/washington-als-clinical-trial/ 2023-01-30T15:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/takeda-seek-label-expansion-ninlaro-multiple-myeloma/ 2018-07-17T10:30:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aurobindo-buys-apotexs-europe/ 2018-07-17T11:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-tpoxx-first-drug-smallpox/ 2018-07-17T11:28:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pliant-funding-fibrotic-programmes/ 2018-07-17T11:31:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-merck-diabetes-drug-china/ 2018-07-16T15:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emas-safety-committee-reduce-xofigo/ 2018-07-16T15:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-recalls-valsartan-products/ 2018-07-16T11:14:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-divest-tapinarof-rights-dermavant/ 2018-07-16T13:10:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-immatics-bispecific-cancer-therapies/ 2018-07-16T10:54:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/type-2-parkinsons/ 2018-07-13T13:01:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/researchers-develop-method-to-create-drugs-without-side-effects/ 2018-07-13T11:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cipla-acquire-mirren/ 2018-07-13T10:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-otsuka-holdings-bioivt-taisho-pharmaceuticals/ 2018-07-13T09:18:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-dr-reddys-laboratories-pluristem-therapeutics-fortress-biotech/ 2018-07-13T09:25:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-split-three-businesses/ 2018-07-13T10:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-submits-venetoclaxs-snda-acute-myeloid-leukaemia/ 2018-07-13T10:25:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cure-therapixs-cannabinoid-non-pain/ 2018-07-12T13:21:36+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/otsuka-purchases-visterra-430m/ 2018-07-12T10:50:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-safety-label-changes-fluoroquinolone-antibiotics/ 2018-07-12T10:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-genevant-rare-disease-drugs/ 2018-07-12T10:08:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/type-2-diabetes-therapeutics/ 2023-05-24T04:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/blocking-generic-competition-will-naming-shaming-work/ 2018-07-11T15:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-price-hikes-rare-cancer-drugs-warrant-higher-prices/ 2021-11-22T14:34:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-reverses-drug-price-hike-trumps-protests/ 2018-07-11T14:10:44+00:00 daily 3.0 https://www.pharmaceutical-technology.com/news/eusa-tivozanib-approved-kidney-cancer-scotland/ 2022-11-25T16:55:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-acquires-mabvaxs-programme-solid-tumours/ 2018-07-11T11:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-terminates-merger-idera/ 2018-07-11T10:55:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-generic-novartis-exelon-patch/ 2018-07-11T10:49:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valley-northern-improved-denaturing-kits-drug-disposal/ 2018-07-10T15:33:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/combining-immune-response-antibiotics-antibiotic-resistant/ 2018-07-10T14:46:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/car-t-therapies-europe/ 2018-07-10T14:11:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-stem-cell-pipeline-for-cardiovascular-and-metabolic-disorders/ 2018-08-01T13:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-removes-key-barrier-us-biosimilar-development/ 2018-07-10T11:04:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hattr-amyloidosis-competing-treatments-closely-matched/ 2018-07-10T10:51:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/side-effect-free-drugs/ 2018-08-03T09:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/axovant-benitec-partner-gene-therapy/ 2018-07-10T10:51:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blood-pressure-drug-verapamil-type1-diabetics/ 2018-07-10T10:41:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/culture-shift-at-takeda-a-sign-of-things-to-come-html/ 2021-11-02T03:25:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glasgow-university-molecular-structure-herpes/ 2018-07-09T14:56:07+00:00 daily 2.0 https://www.pharmaceutical-technology.com/news/uk-regulator-guidelines-costly-add-ons/ 2018-07-09T14:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-sandoz-withdraw-medicines-us-market/ 2018-07-09T11:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/herantis-noninvasive-cdnf-parkinsons/ 2018-07-09T11:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-sprycel-european-approval-ph-cml/ 2018-07-09T12:06:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertex-nhs-impasse-cystic-fibrosis-drug-price/ 2018-07-06T15:15:43+00:00 daily 6.0 https://www.pharmaceutical-technology.com/news/fda-approves-merzs-xeomin-sialorrhea/ 2023-05-15T05:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/43334/ 2023-08-07T04:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinese-acquire-german-amw/ 2018-07-06T11:56:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sanofi-ebos-menarini-asia-pacific-holdings/ 2018-07-06T09:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-expands-drug-manufacturing-china/ 2018-07-06T11:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regulators-recall-valsartan-impurity/ 2019-02-11T10:28:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-catalent-cvc-bain-capital-private-equity/ 2018-07-06T09:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/strong-growth-expected-immunology-market-2016-2023/ 2022-07-22T09:36:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anticoagulants-study-less-bleeds/ 2018-07-05T15:41:19+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/opening-chinese-drug-market/ 2020-01-31T13:46:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apro-pivotal-trials-genitourinary-cancers/ 2022-07-21T04:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/cancer-immunotherapies-drugs-market/ 2018-07-11T15:22:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/binge-eating-disorder-market-growth/ 2018-07-05T10:35:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/catalent-buy-juniper-pharmaceuticals/ 2018-07-05T11:22:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sorrento-lymphatic-delivery/ 2018-07-05T10:59:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/antibiotics-effectiveness-combination/ 2018-07-05T11:22:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/june-2018-top-news-stories-pharma/ 2018-07-06T15:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-research-development-hub-chengdu-china/ 2018-07-04T14:51:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-opdivo-adjuvant-treatment-melanoma/ 2018-07-04T14:08:40+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/skyhawks-star-collaboration-celgene/ 2021-11-25T10:57:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/peanut-allergy-market-set-remarkable-growth-2027/ 2022-12-09T12:36:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/china-enrolment-rate-soars-single-country-trials/ 2018-07-04T09:28:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/insurance-firms-continue-fail-patients-chronic-pain/ 2022-07-11T08:55:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/triple-therapy-prevent-breast-cancer-relapse/ 2018-07-04T11:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aristada-initio-fda-approval-schizophrenia/ 2018-07-04T11:54:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-evotec-complete-integration-infectious-disease-unit/ 2018-07-04T14:03:06+00:00 daily 1.0 https://www.pharmaceutical-technology.com/features/uks-drug-evaluation-system-need-overhaul/ 2018-07-03T15:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fight-ebola-prompts-focus-clinical-trial-design/ 2022-07-11T08:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amazon-set-acquire-pillpack-disrupt-healthcare/ 2018-07-03T14:30:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/epidiolex-cannabidiol-pharmaceutical/ 2018-07-03T10:50:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/venclexta-whats-next-for-abbvies-first-in-class-drug/ 2022-12-28T12:03:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-yescarta-secures-positive-opinion-europes-chmp/ 2018-07-03T10:01:39+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/athenex-forms-new-alliances-asia-expand-oncology-pipeline/ 2018-07-03T10:16:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-broad-institute-expand-heart-therapy-collaboration/ 2018-11-26T10:13:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/interim-phase-ii-data-imbruvica-plus-venclexta-show-deep-cll-remissions/ 2018-07-02T15:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gsks-shingrix-short-supply-rapid-uptake/ 2018-07-02T14:12:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/salix-co-promote-first-non-opioid-withdrawal/ 2023-01-17T09:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ebos-group-australian-distribution-deal/ 2018-07-02T11:46:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/timing-of-new-technology-is-key-to-biologics-api-success/ 2018-07-02T10:39:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/starbucks-approach-will-lead-to-greater-flexibility-in-cdmos/ 2018-07-02T10:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/malaria-eradication-tackling-counterfeit-and-substandard-drugs/ 2018-08-03T09:55:43+00:00 daily 3.0 https://www.pharmaceutical-technology.com/news/akebia-therapeutics-merge-keryx-biopharmaceuticals/ 2018-07-02T11:04:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-plans-spin-off-eye-care-unit-standalone-entity/ 2021-11-02T07:20:32+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/cvc-buy-majority-stake-drugmaker-recordati-e3bn/ 2018-07-02T16:44:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amazon-primed-shake-healthcare-pillpack-acquisition/ 2018-06-29T16:02:06+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/pharma-industry-brexit-regulations/ 2018-06-29T15:49:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biolive-collaborative-areas-within-pharma/ 2018-06-29T15:16:41+00:00 daily 1.0 https://www.pharmaceutical-technology.com/comment/gates-foundations-biotech-thing-selfless-good-deed/ 2018-06-29T15:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/chinese-regulatory-reforms-boon-cdmos-ip-uncertainties-remain/ 2018-06-29T15:17:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-secures-european-nod-lower-dosing-option-meningitis-b-vaccine/ 2018-06-29T10:57:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-increases-stake-samsung-bioepis-700m-deal/ 2018-06-29T10:48:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mapping-malaria-human-contact-help-treat-malaria/ 2023-05-31T04:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-heron-therapeutics-eyepoint-pharmaceuticals-celgene-corporation/ 2018-07-27T06:35:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-advent-international-eli-lilly/ 2018-07-27T06:35:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roches-buyout-foundation-medicine-reaping-benefits-mercks-keytruda/ 2018-06-28T16:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aquinox-halts-development-drug-bladder-pain-syndrome/ 2022-03-29T11:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-influenza-drug-secures-fda-priority-review-status/ 2018-06-28T11:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advent-acquires-sanofis-generics-business-e1-9bn/ 2018-06-28T11:02:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celgene-skyhawk-initiate-five-year-collaboration-neurological-diseases/ 2018-06-27T14:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-72/ 2023-04-21T09:48:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-calibr-partner-develop-t-cell-therapies-cancer/ 2018-06-27T10:13:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-approach-may-eliminate-daily-injections-diabetics/ 2018-06-27T09:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-healthcare-spin-independent-company/ 2018-06-27T10:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kaleido-ends-oversubscribed-funding-round-101m/ 2018-06-26T14:20:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/opdivo-liver-cancer/ 2018-06-26T10:57:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-invest-e230m-biologics-rd/ 2018-06-26T11:12:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-first-cannabis-based-drug-treat-epilepsy/ 2018-06-26T11:00:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/embl-researchers-develop-new-device-test-cancer-drugs/ 2018-06-26T11:02:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-closes-1-6bn-armo-biosciences-acquisition/ 2018-06-25T17:06:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deerfield-acquires-alivamab-mouse-ablexis-antibody-drug/ 2018-06-25T10:57:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-bmss-application-non-small-cell-lung-cancer-treatment/ 2018-06-25T11:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-pharma-companies-immune-us-canada-trade-wars/ 2018-06-22T15:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-alliance-pharma-bayer-onxeo/ 2018-07-27T06:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-distribute-histocyte-laboratories-cell-line-products/ 2018-06-22T10:37:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sugar-can-delay-neurodegeneration-caused-enzyme-deficiency/ 2018-06-22T10:44:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-identify-brain-metals-may-precipitate-alzheimers/ 2018-06-22T10:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/regenerative-therapy-peripheral-artery-disease-moves-forward/ 2023-03-01T08:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/dry-eye-syndrome-pipeline-drugs/ 2018-06-21T15:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/natera-institut-jules-bordet-partner-research-breast-cancer/ 2018-06-21T11:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-drug-reduces-hearing-loss-children-liver-cancer/ 2018-06-21T11:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-buy-remaining-stake-foundation-medicine-2-4bn/ 2018-06-21T11:50:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/shaky-foundations-flaws-animal-research-reporting/ 2018-06-20T16:34:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-shows-almost-half-uk-women-experience-serious-trouble-contraception/ 2018-06-26T11:13:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-becomes-first-canadian-pharmaceutical-company-enter-medical-cannabis-field/ 2018-06-20T15:19:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/worlds-biggest-pharmaceutical-companies-2018/ 2024-05-10T07:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/viiv-ups-ante-positive-topline-data-second-two-drug-hiv-combo/ 2018-06-20T14:34:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/thailand-medical-tourism-contract-manufacturing/ 2018-06-29T15:16:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pharma-underutilises-avenues-attract-retain-trial-patients/ 2018-06-20T11:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ema-approval-trazimera-another-win-trastuzumab-biosimilars/ 2018-06-20T10:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eha-2018-competition-heating-dlbcl-anti-cd19-car-t-cell-therapies/ 2018-06-19T17:21:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ean-congress-2018-refractory-migraine-problem-prevention/ 2018-06-19T17:11:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ean-congress-2018-brain-disorders-value/ 2018-06-19T16:59:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-completes-3-9bn-acquisition-ablynx/ 2018-06-20T11:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-immunogens-treatment-ovarian-cancer/ 2018-06-20T10:59:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-hpv-vaccine-reduces-cancer-causing-infection-86/ 2018-06-20T10:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ean-congress-2018-adaptation-key-managing-non-routine-parkinsons/ 2018-06-19T16:40:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eha-2018-pivotal-phase-iii-data-daiichi-sankyos-quizartinib/ 2018-06-19T16:36:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ean-congress-2018-microrna-biomarkers-future-als-diagnosis/ 2018-06-19T16:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eha-2018-can-biosimilars-implemented-worldwide-promote-sustainability/ 2018-06-19T16:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-presents-data-esketamine-nasal-spray-depression/ 2021-12-01T12:44:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/talking-generics-in-the-uk-with-mylans-jean-yves-brault/ 2018-06-19T12:51:57+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/fda-awards-prv-not-profits-river-blindness-treatment/ 2018-06-19T10:11:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-approves-immunooncology-agent-opdivo-previously-treated-nsclc/ 2018-06-19T10:50:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-resubmits-marketing-approval-fda-trastuzumab-biosimilar/ 2018-06-19T11:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/university-leicester-finds-new-way-assess-men-b-vaccine-effectiveness/ 2018-06-19T11:07:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-court-issues-restraint-order-dr-reddys-new-drug/ 2018-06-18T15:40:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-finds-jakavi-can-help-real-world-blood-cancer-patients/ 2022-07-11T08:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-suboxone-generic-variant-treat-opioid-dependence/ 2018-06-18T10:22:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eular-2018-key-pipeline-developments-psoriatic-arthritis/ 2018-06-15T14:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-sells-lifescan-private-equity/ 2021-06-01T09:17:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/innovators-watch-tlas-healthtech-innovator-conference/ 2018-06-15T10:53:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/lanabecestat-termination-another-blow-bace-inhibitors/ 2018-06-15T09:47:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eular-2018-focus-infliximab-biosimilars-rheumatoid-arthritis/ 2018-06-15T09:48:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizers-blockbuster-drug-lyrica-comes-off-patent-2018/ 2024-05-10T07:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-gene-therapies-may-see-success-regulatory-oncology-updates/ 2018-06-15T09:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sage-shionogi-advance-depression-drug-asia/ 2018-06-15T10:22:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-mas-week-alexion-pharmaceuticals-recipharm-astrazeneca/ 2018-07-27T06:35:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-keytruda-gets-us-approval-pmbc-lymphoma/ 2018-06-15T11:23:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ten-promising-cancer-drugs-trialled/ 2022-07-11T08:55:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-nordic-nanovectors-betalutin-follicular-lymphoma/ 2018-06-14T11:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-set-dementia-research-facility-us/ 2018-06-14T11:10:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-nice-issues-positive-guidance-janssens-tremfya/ 2018-06-14T11:45:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/formula-success-inside-swiss-pharma/ 2020-01-27T05:11:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/northwest-bios-dcvax-l-hype-warranted-glioblastoma-patients/ 2022-07-11T08:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-suggests-new-reimbursement-idea-antimicrobial-drugs/ 2018-06-13T13:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-data-sees-mercks-keytruda-pull-ahead-roches-tecentriq-lung-cancer/ 2018-06-13T11:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/single-country-studies-dominate-immuno-oncology-trials-2008-2017/ 2018-06-13T10:52:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/eli-lillys-olumiant-will-far-among-jak-inhibitors/ 2018-06-13T10:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cancer-research-uk-initiate-trial-for-immunotherapy-vaccine/ 2018-06-13T11:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/denali-abcellera-collaborate-treating-neurodegenerative-disease/ 2018-06-13T13:38:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-maxcyte-develop-new-sickle-cell-disease-therapies/ 2022-12-09T12:29:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/efficacy-bar-unclear-celgenes-phase-iii-abraxane-gemcitabine/ 2018-06-12T14:31:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gut-instinct-common-drugs-affect-microbiome/ 2018-06-12T11:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/unmet-needs-must-addressed-optimise-ais-management/ 2018-06-12T11:07:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-roches-polatuzumab-vedotin-results-show-promise-dlbcl/ 2018-06-12T10:15:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-abbvies-venclexta-chronic-lymphocytic-leukaemia/ 2018-06-12T09:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-receives-european-clearance-lung-cancer-drug/ 2018-06-12T11:00:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-pasteur-translate-bio-develop-new-mrna-vaccines/ 2018-06-12T09:42:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unlocking-cell-free-protein-synthesis-biotechs-next-big-ticket/ 2018-06-11T16:10:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-mercks-keytruda-top-first-line-nsclc/ 2018-06-11T15:06:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/opportunity-gene-therapies-oncology/ 2018-06-12T11:05:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-wins-appeal-cma-fine-epilepsy-drug-price/ 2018-06-11T11:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-evolving-role-supportive-care-oncology/ 2018-06-11T11:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazenecas-fasenra-find-use-niche-asthma-copd-overlapping-group/ 2023-01-04T10:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-builds-worlds-first-fully-automated-drug-discovery-facility/ 2018-06-15T09:07:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ema-accept-marketing-application-pfizers-talazoparib/ 2018-06-11T10:51:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-chinese-scientists-partner-new-medicines-epidemics/ 2018-06-11T11:48:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-provides-flexfactory-platform-xiangxue-pharmaceutical/ 2018-06-11T10:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aduro-starts-phase-1b-trial-immunotherapy-treatment-lung-cancer/ 2022-07-11T08:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-lag-3-next-checkpoint-target/ 2018-06-08T10:49:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-will-jcar017-become-third-car-t-product-lymphoma/ 2018-06-08T10:43:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-roche-discusses-tmb-predictive-biomarker-nsclc/ 2018-06-08T10:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-optinose-kitov-pharma-clovis-oncology/ 2018-07-27T06:35:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-partners-boston-university-tackle-lung-cancer/ 2018-06-08T10:28:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-microbiotica-develop-new-ibd-medicines/ 2018-06-08T10:44:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-intermediate-capital-group-novartis/ 2018-07-27T06:35:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-acquires-licence-japanese-firm-tms-stroke-asset/ 2018-06-08T10:36:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/positive-vaccine-study-vbi-looks-untapped-congenital-cmv-market/ 2018-06-07T14:51:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-files-legal-complaint-biodefense/ 2018-06-07T13:45:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-ai-reveal-complex-patterns-biological-data/ 2019-12-23T10:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/holistic-approach-disease-may-bring-true-pharma-innovation/ 2018-06-07T10:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/shorter-antibiotic-courses-health-benefits-evidence-needed/ 2018-06-07T09:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-hookipa-develop-new-hiv-hbv-drugs/ 2018-06-07T11:31:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/axovant-buys-rights-oxford-biomedicas-parkinsons-candidate/ 2018-06-07T11:23:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fully-automated-facility-drug-discovery-built-uk/ 2018-06-08T10:03:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/bipolar-disorder-understanding-a-multifaceted-mental-condition/ 2018-06-06T15:34:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-rejects-ipsens-cabometyx-treatment-renal-cancer-nhs/ 2018-06-06T13:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-interchangeability-studies-limited-benefit-us-uptake/ 2018-06-06T12:27:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-china-trade-war-wipe-us-based-generics-manufacturing/ 2018-06-07T09:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nihs-study-shows-positive-outcomes-experimental-hiv-vaccine/ 2018-06-06T10:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-warns-illicit-online-opiod-marketers/ 2018-06-06T11:34:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mylan-biocons-biosimilar-neulasta-gains-fda-approval/ 2023-03-08T09:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/visualising-biologics-discovery-dealing-complex-data/ 2018-06-05T16:03:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-merck-record-improved-survival-combination-treatment-mcrpc/ 2018-06-05T15:41:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-cimzia-approval-secure-ucbs-position-immuno-dermatology/ 2018-06-05T13:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/g-protein-coupled-receptor-signaling-set-dominate-womens-health-therapy-market/ 2018-06-05T12:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-unveils-new-data-ustekinumab-treatment-crohns-disease/ 2018-06-05T14:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-combinations-vs-single-agent-melanoma-immunotherapy/ 2018-06-05T10:56:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asco-2018-revlimid-results-superior-safety-worth-cost/ 2018-06-05T10:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/metformin-can-reduce-deaths-heart-circulatory-diseases/ 2023-05-22T08:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lillys-olumiant-gets-us-approval-treat-rheumatoid-arthritis/ 2018-06-05T11:00:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-chmp-recommends-akceas-rare-disease-drug/ 2018-06-05T10:53:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/may-2018-top-news-stories-pharma/ 2018-06-05T10:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/exelixis-invenra-partner-oncology-drug-development/ 2018-06-04T12:57:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/deployment-mercks-rvsv-zebov-combat-ebola-marks-crossroads-vaccine-rd/ 2018-06-04T12:47:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-suggests-breast-cancer-patients-no-benefit-chemotherapy/ 2018-06-04T13:09:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-signs-oncology-collaborations-md-anderson/ 2018-06-04T10:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-divests-stake-joint-venture-gsk/ 2018-06-04T10:35:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-premier-develop-solutions-c-diff-infection/ 2018-06-04T10:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-releases-draft-guidance-policies-improve-generic-drugs-access/ 2018-06-01T14:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-therapies-miraculous-cures-sustainable-business-model/ 2018-06-01T10:50:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/manipulating-fda-safety-protocols-maintain-market-dominance-right/ 2018-06-01T10:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/schrodinger-canadas-cdrd-partner-develop-cancer-biologics/ 2018-06-01T11:12:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-reports-positive-data-esketamine-treat-depression/ 2018-06-01T11:12:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-sanofi-alibaba-group-amneal-pharmaceuticals/ 2018-07-27T06:35:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/indias-use-unapproved-antibiotics-undermine-global-health/ 2018-05-31T14:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abivax-believes-made-progress-towards-hiv-cure/ 2018-05-31T14:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-new-drug-application-novartis-promacta/ 2018-05-31T14:09:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/analysis-oncology-pipeline/ 2018-05-31T10:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-develop-new-inflammatory-disease-drugs/ 2018-05-31T10:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aptar-propeller-health-partner-digital-medicines-platform/ 2018-05-31T10:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-grants-priority-review-astellas-nda-gilteritinib/ 2018-05-31T10:40:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/another-bace1-failure-alzheimers-little-late/ 2018-05-30T14:12:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-biomarins-enzyme-substitution-therapy-treat-pku/ 2022-11-24T12:11:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gene-therapies-continue-demonstrate-strong-commercial-appeal/ 2018-05-31T10:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-recalls-order-contraceptive-capsules/ 2018-05-30T11:10:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-proposes-adjustment-pharma-intellectual-property-rules/ 2018-05-30T11:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-extends-master-services-agreement-beactica/ 2018-05-30T10:43:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asgct-2018-electroporation-mediated-gene-delivery-coronary-artery-disease/ 2018-05-29T15:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uk-dominates-european-cell-therapy-contract-manufacturing-services/ 2018-05-29T14:58:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asgct-2018-bringing-cell-gene-therapies-inception-commercialisation/ 2018-05-29T14:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alibaba-sell-medical-assets-hong-kong-unit-1-35bn/ 2018-05-29T13:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avara-pharmaceutical-to-buy-novartis-production-plant-canada/ 2018-05-29T13:08:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-outlines-roadmap-tackle-alzheimers-disease/ 2018-05-29T11:25:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/can-gene-cell-therapy-revolution-scale/ 2022-03-23T10:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ema-post-brexit-will-uk-become-second-tier-state/ 2018-05-25T15:53:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asgct-2018-pricing-allow-fair-access-gene-based-therapies/ 2018-05-25T15:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-biosimilar-market-forecast-reach-99-28bn-2024/ 2018-05-25T14:31:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-decide-tevas-migraine-treatment-september/ 2018-05-25T14:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/artificial-intelligence-future-drug-discovery/ 2018-05-25T10:14:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-commission-approves-sandozs-biosimilar-zessly/ 2018-05-25T11:13:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-datinvest-shanghai-pharmaceuticals-sunrise-bright-investment/ 2022-07-28T08:10:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-pharma-professionals-uk-not-expect-relocation-brexit/ 2018-05-25T11:08:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-cipla-takeda-pharmaceutical-cadila-healthcare/ 2018-05-24T10:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-gets-breakthrough-status-fda-cardiomyopathy-drug/ 2018-05-25T11:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-claims-chemotherapy-effective-combined-keytruda/ 2018-05-24T15:54:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esperion-reports-success-study-reduce-ldl-c-levels/ 2018-05-24T15:37:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-71/ 2023-04-12T06:15:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-certifies-new-drug-thrombocytopenia/ 2023-03-23T10:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/aimovig-marks-new-milestone-migraine/ 2018-05-24T11:38:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/chinas-enrolment-rate-dips-phase-rises/ 2018-05-24T09:11:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allergan-buy-aptinyxs-depression-drug-candidate/ 2018-05-24T11:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-reviews-sanofis-application-type-1-diabetes-drug/ 2018-05-24T11:34:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-forms-new-alliances-improve-cancer-outcomes/ 2018-05-24T11:01:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sells-stake-techpool-acquiring-shire/ 2018-05-23T15:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/39605/ 2018-05-23T15:18:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/crispr-seismic-shift-gene-editing/ 2018-05-23T13:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-congress-approves-right-try-bill/ 2018-05-23T11:32:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/fda-companies-generics-manufacturing/ 2018-05-23T09:47:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-signs-cancer-drug-development-alliance-celgene/ 2018-05-23T09:42:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mit-team-develops-single-injection-polymer-vaccine-polio/ 2018-05-23T09:35:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sell-chinese-jv-techpool-280m/ 2018-05-23T09:45:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fit-biotech-avacta-announce-positive-results-pilot-affimer-delivery-study/ 2018-05-22T15:40:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-astrazenecas-hyperkalaemia-drug/ 2018-05-22T11:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/amgen-seeks-second-chance-imlygic-competitive-melanoma-market/ 2022-03-23T16:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/evolving-story-ido-1-inhibitors-fall-grace/ 2023-01-05T06:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-european-network-focus-paediatric-medicines/ 2018-05-22T11:20:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-secures-european-approval-new-hiv-1-treatment/ 2018-05-22T09:40:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harmony-gets-breakthrough-fast-track-status-pitolisant/ 2018-05-22T09:25:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/nevermore-ignore-the-role-of-digital-health-html/ 2021-11-02T03:25:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-fda-evaluate-link-hiv-drug-birth-defects/ 2018-05-21T16:02:05+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/commonwealth-ministers-pledge-combat-ncds/ 2018-05-21T14:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/us-worldmeds-lucemyra-may-key-controlling-us-opioid-crisis/ 2018-05-21T10:36:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-japanese-flu-treatment-game-changer/ 2018-05-21T10:10:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nohla-series-b-financing/ 2018-05-21T09:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/opportunity-abounds-pharma-binge-eating-disorder-marketplace/ 2022-12-12T14:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-obtains-us-approval-migraine-drug-aimovig/ 2018-05-21T11:45:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspirin-combination-therapy-can-reduce-secondary-stroke-risk/ 2018-05-21T11:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/short-term-herceptin-use-can-work-specific-breast-cancer/ 2018-05-21T11:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-beis-report-calls-pharmaceutical-post-brexit-deal/ 2018-05-18T09:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-eli-lilly-fujifilm-holdings-canopy-growth/ 2018-05-21T13:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-worldmeds-gets-fda-approval-lucemyra/ 2023-05-10T05:36:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-bolsters-focus-stem-cell-based-therapies/ 2018-05-18T09:23:28+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/deals-week-glaxosmithkline-ligand-catalent-pharma-solutions/ 2018-05-21T14:09:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/ispor-2018-baltimore-html/ 2021-11-02T03:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-doctors-proposal-healthcare/ 2018-05-17T16:22:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fixing-drug-price-crisis-us/ 2018-05-17T15:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/roclatan-nda-submission-puts-glaucoma-drug-track-2019-us-launch/ 2022-09-14T11:12:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/kite-netherlands-cell-therapy/ 2018-05-17T08:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-closes-8-7bn-acquisition-avexis/ 2018-05-17T11:15:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eiger-expands-lonafarnib-licensing-deal-merck/ 2018-05-17T10:22:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-pfizers-retacrit-biosimilar-treat-anaemia/ 2018-05-17T09:19:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/drug-supply-shortages-in-germany-html/ 2021-11-02T03:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-alex-azar-medicare-part-b/ 2018-05-16T16:26:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-drug-results-cluster-headache/ 2018-05-16T08:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tapimmune-agrees-merge-marker-therapeutics/ 2018-05-16T13:39:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/danish-researchers-identify-around-100-cancer-targets/ 2018-05-16T11:33:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beam-receives-gene-editing-technology-licence-harvard/ 2018-05-16T13:34:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/t-cell-biomarkers-show-promise-car-t-therapy-cll-enough/ 2018-05-15T15:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/trump-drug-pricing-speech/ 2018-05-15T14:40:39+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/medigene-bluebird-tcr-partnership/ 2018-05-15T09:11:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-novartis-gilenya-treat-paediatric-multiple-sclerosis/ 2018-05-15T10:37:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-buy-canadas-aurka-pharma-110m-upfront/ 2018-05-15T10:44:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/big-data-used-analyse-animal-studies-ability-predict-human-safety/ 2018-05-15T15:37:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-boosts-brain-cancer-research-40m-funding/ 2018-05-15T12:07:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biotech-ma-will-2018-surge-last/ 2018-05-14T14:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ubrogepant-trial-results-set-secure-allergans-future-migraine-market/ 2022-07-11T08:55:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-president-trump-unveils-plan-lower-prices-drugs/ 2018-05-14T11:12:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-finding-help-predict-cancer-resistance-parp-inhibitors/ 2018-05-14T16:19:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-recommends-akceas-chylomicronemia-drug/ 2018-05-14T10:49:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astra-zeneca-copd-trial-fasenra/ 2018-05-14T13:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-tecentriq-fails-trial/ 2018-05-11T15:36:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazeneca-continues-invest-stem-cell-research/ 2018-05-11T14:20:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/abbvies-risankizumab-edges-closer-approval-moderate-severe-psoriasis/ 2018-05-11T14:02:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-seeks-shut-stem-cell/ 2018-05-11T11:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inside-canadas-centre-drug-research-development/ 2018-05-11T10:44:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-armo-biosciences/ 2018-05-11T09:27:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-strides-shasun-takeda-pharmaceutical-eli-lilly/ 2018-05-11T09:23:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-mannkind-xtalpi-ascendia-pharmaceuticals/ 2018-05-11T09:33:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apotex-strides-combine-australian-new-zealand-businesses/ 2018-05-11T10:39:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vyriad-construct-oncolytic-virus-vaccine-production-facility-us/ 2018-05-11T11:39:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/allen-institute-launches-3d-model-live-human-cell/ 2018-05-11T10:25:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/impact-of-passing-through-rebates-html/ 2021-11-02T03:27:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cphi-experts-90-current-pipeline-apis-poorly-soluble/ 2018-05-10T10:52:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cphi-experts-warn-possibility-catastrophic-success-cell-therapy-manufacturing/ 2018-05-10T10:32:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fda-novartis-thyroid-tafinlar/ 2018-05-10T09:18:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lannett-generic-drugs-endo/ 2018-05-10T08:58:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-announces-eu-approval-lynparza-ovarian-cancer/ 2018-05-10T09:57:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lodo-signs-drug-discovery-deal-genentech/ 2018-05-10T10:29:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/xtalpi-pfizer-develop-ai-software-identify-new-drugs/ 2018-05-10T10:16:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/novartis-payments-cohen-trump/ 2018-05-15T16:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/experts-clinical-trial-transparency/ 2022-07-11T08:55:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unlocking-potential-chinese-medicine/ 2018-05-09T14:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/dermatology-pharmas-latest-focus/ 2023-05-19T03:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-trial-study-kidney-transplants-hiv-patients/ 2018-05-09T09:53:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-agrees-totakedas-46bn-acquisition-offer/ 2018-05-09T16:13:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-janssens-darzalex-treat-multiple-myeloma/ 2018-05-09T09:21:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esketamine-depression-ketamine/ 2023-03-27T13:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/golden-age-cdmo-industry-retrospective-jim-miller/ 2018-05-08T14:39:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-fund-will-address-misuse-drugs-uk-care-homes/ 2018-05-14T10:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/china-india-import-tariffs/ 2018-05-08T10:20:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-secures-fda-priority-review-status-tecentriq/ 2018-05-08T10:27:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-sell-rights-seroquel-luye-pharma-538m/ 2018-05-08T11:38:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-bidmc-opens-immunotherapy-research-institute/ 2018-05-08T09:56:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/first-quarter-report-teva/ 2018-05-04T15:51:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bristol-myers-squibb-flatiron-rwe/ 2018-05-04T11:09:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-mdma-ptsd/ 2018-05-04T10:55:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/gileads-hcv-portfolio-disappoints-amid-pressure-abbvies-mavyret/ 2018-05-04T10:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/worlds-first-car-t-therapy-approved-second-indication/ 2018-05-04T09:02:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-forms-alliance-advance-abituzumab-colorectal-cancer/ 2018-05-04T09:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-intelgenx-oasmia-pharmaceutical-karo-pharma/ 2018-05-04T10:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordics-chordoma-vaccine-secures-orphan-drug-status/ 2021-11-22T06:41:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/2018-april-top-stories-pharma/ 2021-11-24T05:37:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-united-therapeutics-par-formulations-endo-ventures/ 2018-05-04T10:11:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-researchers-develop-new-cure-bone-diseases/ 2018-05-04T10:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-fda-approval-kymriah/ 2018-05-03T09:21:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-acquire-benevir-biopharm-1bn/ 2018-05-03T10:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-submits-application-ema-psoriasis-drug-approval/ 2018-05-03T14:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/researchers-call-alternative-hiv-therapy-approaches/ 2018-05-03T14:12:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/boosting-biosimilar-uptake-us-needs-change/ 2021-07-30T15:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immune-car-t-cell-therapy/ 2018-05-02T13:32:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/positive-chmp-opinion-prolia-label-expansion-will-boost-sales/ 2018-05-02T13:30:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssens-psoriasis-drug-fad-nice/ 2018-05-02T13:07:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/united-therapeutics-purchase-steadymed-216m-deal/ 2018-05-02T10:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ironwood-pharmaceuticals-divide-two-companies/ 2018-05-02T10:09:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-gets-us-approval-adjuvant-therapy-treat-melanoma/ 2018-05-02T09:46:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acadia-shares-fda-investigation/ 2021-12-02T06:38:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-biologics-build-e325m-biomanufacturing-facility-ireland/ 2018-05-01T11:39:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-restructure-vaccines-subsidiary/ 2018-05-01T12:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ani-pharma-acquire-assets-amneal-impax/ 2018-05-01T09:48:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-merck-bladder-cancer-keytruda/ 2018-04-30T16:24:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/humira-biosimilars-launch-eu-year-will-uptake-similar-remicade-biosimilars/ 2018-04-30T11:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/cured-but-at-what-cost/ 2018-04-30T10:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/autism-prevalence-rises-us-children/ 2023-01-23T12:46:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-chmp-recommends-gileads-biktarvy-treat-hiv-1/ 2018-04-30T13:18:43+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/bms-forms-collaboration-study-lupus-drug/ 2018-04-30T10:21:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/digital-tech-unlock-billions-savings-pharma-companies/ 2018-04-27T15:27:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/takeda-chases-largest-deal-yet/ 2018-04-27T13:09:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-ctd-holdings-peptron-hemispherx-biopharma/ 2018-04-26T16:31:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-astrazeneca-mega-labs-toho-holdings/ 2018-04-26T16:34:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/report-small-biotech-firms-lead-microbiome-targeted-therapy-space/ 2018-04-27T10:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-forms-chinese-alliance-diabetes-care/ 2018-04-27T09:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/proteus-digital-health-develops-pipeline-31-digital-drugs/ 2018-04-27T10:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anticholingeric-antidepressants-dementia/ 2018-04-26T16:15:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celldex-workforce-trial-failure/ 2018-04-26T16:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/creates-act-dropped-may-still-see-progress/ 2018-04-26T15:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pan-cancer-atlas-will-validate-precision-medicine-approaches/ 2018-04-26T09:54:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-q1-report-fall-earnings/ 2018-04-30T08:55:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/natural-barcode-helps-track-cells-genetic-information/ 2018-04-26T09:55:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/india-teams-world-bank-boost-healthcare-sector/ 2018-04-26T10:23:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nektar-takeda-test-combination-regimen-cancer/ 2018-04-26T09:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/research-orphan-drug-europe/ 2018-04-25T16:24:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/tracing-story-mumps-timeline/ 2024-08-21T05:33:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/focusing-user-experience-reinvent-drug-rd-software/ 2018-04-25T13:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/world-malaria-day-2018-achieve-eradication-malaria-transmission-must-stopped/ 2018-04-25T10:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/world-malaria-day-who/ 2018-04-25T10:26:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/late-stage-type-2-diabetes-pipeline-dominated-drugs/ 2023-03-20T10:40:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/hemlibra-receives-fda-breakthrough-therapy-designation/ 2018-04-24T14:44:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tweaking-diabetes-treatments-can-improve-effectiveness/ 2018-04-25T10:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/topas-partners-boehringer-vector-based-drugs/ 2018-04-25T11:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/ketamine-may-become-key-therapy-treatment-depression/ 2018-04-24T15:22:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/state-us-somatic-cell-therapy-facilities/ 2018-04-24T13:41:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/new-therapy-set-dominate-hiv-market/ 2018-04-24T12:51:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tremfya-approval-increasing-options-psoriasis-treatment/ 2018-04-24T12:49:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/blockbuster-immunology-drugs-facing-patent-expiry-biosimilar-competition/ 2018-04-24T10:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-offer-shire-takeover/ 2018-04-24T09:14:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-ionis-develop-neurological-drugs-1bn-deal/ 2018-04-24T09:54:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizers-trumenba-gets-breakthrough-status-meningococcal-disease/ 2018-04-24T10:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/belgiums-ucb-buys-proximagens-epilepsy-drug/ 2018-04-24T10:47:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fresenius-akorn-deal/ 2018-04-23T16:32:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dea-rules-manufacture-opioids/ 2018-04-23T16:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanomedicine-coating-technique-improves-drug-delivery/ 2018-04-23T15:32:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/experts-call-review-pharma-manufacturing-processes/ 2018-04-23T11:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/pfizer-funds-creakyjoints-initiative-shared-decision-making-rheumatoid-arthritis/ 2018-04-23T10:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/world-immunisation-week-2018-spotlights-remaining-vaccine-coverage-gaps/ 2018-04-23T10:40:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-committee-cbd-epilepsy/ 2018-04-23T08:28:58+00:00 daily 1.0 https://www.pharmaceutical-technology.com/news/phrma-report-neurological-drugs/ 2018-04-23T08:19:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pg-buys-mercks-consumer-health-business-4-2bn/ 2021-10-25T09:01:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/queensland-focuses-new-drug-motor-neurone-disease/ 2018-04-23T10:29:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tocagen-licences-cancer-immunotherapy-apollobio/ 2018-04-23T09:57:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/jj-discontinues-development-c-difficile-antibiotic-cadazolid/ 2018-04-20T12:52:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/marijuana-possible-solution-opioid-crisis/ 2018-04-20T09:11:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/sanofis-next-steps-following-nices-rejection-dupixent/ 2018-04-20T08:49:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deals-week-clovis-oncology-les-laboratoires-servier-bayer/ 2018-04-20T09:16:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-wacker-biotech-pacific-glory-development-proteintech-group/ 2018-04-20T09:28:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/benevolentai-raises-115m-to-boost-ai-based-drug-development/ 2023-02-23T05:37:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-approves-astrazenecas-tagrisso-for-nsclc/ 2018-04-20T10:41:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-turns-down-takedas-44bn-takeover-bid/ 2018-04-20T09:53:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-ema-regulation-brexit/ 2018-04-19T16:28:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-issue-70/ 2023-04-12T06:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/adocia-blood-sugar-technology/ 2018-04-19T10:18:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sempre-health-novo-nordisk-diabetes/ 2018-04-19T09:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/can-ai-blockchain-tech-help-bring-drug-prices/ 2023-02-06T07:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/novo-nordisk-red-cross-ncds/ 2018-04-19T09:38:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ge-creates-ready-run-factory-viral-vector-drugs/ 2018-04-19T11:47:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-pear-create-digital-therapeutics-opioid-use-disorders/ 2023-05-10T05:35:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-fast-tracks-roches-hemlibra-haemophilia/ 2018-04-19T11:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/us-tariffs-likely-to-mostly-affect-us-generics-makers-html/ 2021-11-02T03:27:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-grants-priority-review-verastems-duvelisib-toxicities-weaken-prospects/ 2018-04-18T10:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/anaptysbios-anb-020-remains-strong-potential-contender-peanut-allergy-market/ 2018-04-18T09:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/incytes-clinical-trial-flop-indicates-uncertain-future-ido-inhibitors/ 2022-07-11T08:55:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-cancer-drug-trials-imfinzi/ 2018-04-18T09:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-lilly-support-new-chronic-kidney-disease-study/ 2022-12-03T08:46:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mit-researchers-create-artificial-antimicrobial-peptides/ 2018-04-18T10:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/advent-talks-buy-sanofis-generics-business-e1-9bn/ 2018-04-18T10:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/astrazeneca-deal-shows-promise-molecular-partners-lung-cancer-therapy/ 2018-04-18T09:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/canada-drug-fined-counterfeit-drugs/ 2018-04-17T15:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/azeliragon-third-alzheimers-failure-2018/ 2023-07-17T13:07:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/su2c-lustgarten-partner-drive-pancreatic-cancer-research/ 2018-04-17T10:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-approach-enhances-gene-editing-accuracy/ 2018-04-17T11:29:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-janssen-partner-develop-cardiovascular-therapy/ 2018-04-17T11:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-vaccine-manufacturing-ghana/ 2018-12-10T10:17:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mercks-new-collaboration-aims-affordable-vaccines/ 2018-04-16T11:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/silenced-immune-cells-can-activated-fight-diseases/ 2018-04-16T11:45:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shire-divest-oncology-unit-frances-servier-2-4bn/ 2018-04-16T14:17:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/biosimilar-frontrunner-celltrion-lose-first-market-advantage-truxima-us/ 2018-04-13T10:30:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mas-week-novartis-roche-alexion/ 2018-04-13T08:51:41+00:00 daily 0.2